Scandinavian Tobacco Raised Guidance on a Refund and a Shipping Calendar
The Q3 beat was DKK 70m of pulled-forward shipments and a duty windfall — while the market-share recovery quietly moved to 2027 and the buyback got deferred for a third straight call
STG.CO · Earnings Call · 2026-11-12
The raise that isn't a recovery
Scandinavian Tobacco Group lifted the middle of its guidance on 12 November: EBIT margin before special items to 14–15.5% from 13–14.5%, adjusted EPS to DKK 9.5–11.5 from DKK 9–11. Management framed it as "the year-to-date financial performance and higher-than-expected tariff and duty refunds." Read the two halves of that sentence separately and the story changes character.
The 9-month numbers look fine at face value: net sales of DKK 6.6bn broadly flat, organic growth of just +0.5%, EBIT margin before special items up to 16.1% from 15.0%, and a Q3 margin of 19.9% versus 17.3%. But the quarter carried roughly DKK 70m of net sales that simply arrived early — “Q3 is probably impacted by around DKK 70 million in net sales that we would call phasing.” — Marianne Bock, Chief Financial Officer (CFO) · 2026-11-12 Marianne Bock was explicit that this reverses: "both EBIT and the EBIT margin will be lower in the fourth quarter compared with last year." The company is raising the full year while telling you the exit rate is deteriorating. Strip out the phasing and Q3's +2.1% organic growth, and group organic sales are roughly flat.
Timing of shipments: the quarter's defining keyword
The keyword data captures this better than the press release. timing of shipments is the company's single highest-ranked theme this quarter — not a product, not a strategy pillar, a calendar artefact. Machine-rolled cigars and smoking tobacco posted +7% organic growth and a 57.4% gross margin in Q3, with the 9-month category margin at 53.8% versus 50.9%. The CFO attributes the improvement to positive results... but the mechanism was described plainly: restocking shelves after the quality problem plus pre-loading markets ahead of an SAP wave. That is a one-quarter gift, and management said so.
What makes this worth flagging is that the underlying operating story is genuinely improving — just far more slowly than the print suggests. signs of stabilization is fair language for a category that has been bleeding share for years. It is not fair language for a 7% growth quarter.
A global refund wave, not a company insight
Here is where STG joins a very crowded room. tariff refund and duty refund are two of STG's freshest high-momentum themes — and they are also one of the loudest cross-sectional themes in the entire market. The global keyword set has Tariff Refund as the top-ranked market theme in the 2026Q2 window, with Supreme Court decision riding alongside it after the US court struck down the tariff regime and opened the reclaim window. In the last five days alone, Alamo, CNH, Diageo-adjacent Dorel, On Holding, WW International, Grove and STG itself have all booked net tariff refund benefit — and the tape has started paying for it, with refund beneficiaries among the better 30-day movers.
STG's version is modest and lumpy. Other income of DKK 116m over nine months is duty drawback; Q3 contributed DKK 37m; there were no tariff refunds in Q3 because those landed in Q2. Q4 is expected to bring about DKK 50m combined, after Bock corrected herself mid-answer from Q3 to Q4. So the upgraded guidance leans on roughly DKK 50m of Q4 windfall plus a phasing benefit that then reverses. That is a lower-quality raise than the headline implies, and the fact that a dozen other companies are booking the same item means it carries no informational edge about STG's franchise.
The 2027 promise, and the buyback that never comes
The genuinely new news is timing slippage on market share. In August, Niels Frederiksen told the same audience that “in the course of Q3, we will be back to normal inventory levels in the trade.” — Niels Frederiksen, Chief Executive Officer · 2026-08-27 He delivered on the inventory. He did not deliver on the share — and this quarter he pushed the test out: “you have to go into 2027 before you start seeing whether we can successfully raise the market share back up again.” — Niels Frederiksen, Chief Executive Officer (CEO) · 2026-11-12 The loss is concentrated in Signature, a brand that was working. Note also that quality issue, the second-ranked theme last quarter, has quietly slid down the agenda — declared resolved, and now more of an explanation than a topic. Meanwhile divestment of BREAK and Moro is doing real work on the P&L optics: those brands were almost 4% of group sales and slightly more than 6% of EBITDA, and from 2027 they become lower-margin contract manufacturing.
The third act is capital allocation, and it is the most interesting tension in the transcript. Leverage fell to 2.7x from 3.0x, and with divestment proceeds plus Q4 cash, management expects roughly 2x by year-end — below the 2.5x target. leverage ratio discipline, previously the whole justification for a paused buyback, is now satisfied. And still no buyback. In August Bock said “It's too early for us to say anything about capital allocation and resuming share buybacks.” — Marianne Bock, Chief Financial Officer · 2026-08-27 In March, asked whether buybacks were unlikely in 2026, she answered “I think the short answer is yes.” — Marianne Bock, CFO or Senior Finance Executive · 2026-03-05 November brings a third deferral: “we will revert no later than in March.” — Marianne Bock, Chief Financial Officer (CFO) · 2026-11-12 Three quarters, one answer, a balance sheet that is now visibly under-levered versus target, and a shareholder return policy that awaits clarity on 2027 momentum. The cash flow generation is there — free cash flow before acquisitions of DKK 862m for nine months, close to double last year — but the distribution decision keeps sliding.
The optionality nobody is paying for
Two smaller threads deserve attention. First, next-generation products: organic net sales fell 6%, yet in-market volumes across Sweden, Denmark and the UK rose 19% with STG's brands up 25%, and XQS hit an all-time-high 13.8% Swedish share. That gap is investment and portfolio pruning, not demand decay — the classic case of reported revenue understating a franchise. The German launch of chew bags is explicitly a regulatory placeholder rather than a business: “nicotine pouches is not legal in Germany. But the product of chew bags, in our opinion is” — Niels Frederiksen, Chief Executive Officer (CEO) · 2026-11-12 — a bet on future liberalisation, priced today as opex. Compare that caution with the broader market's noise around flavour-product regulation and it reads as disciplined.
Second, the US handmade cigar market is declining slightly less than the feared minus 4%, and management claims share gains there. That is the one category where the strategy is unambiguously working, and it is the one the market gives least credit for.
So what changed? Not the franchise. The quarter changed because a shipping calendar and a US court handed STG DKK 120m-odd of help, and management used it to lift guidance while simultaneously flagging a weaker Q4, a share recovery that now needs another year, and a capital return decision that has been pending since March. The stock is a small-cap defensive with a genuinely improving cash engine and a management team that has now spent four quarters asking for patience. Patience is cheap to request and expensive to keep granting — and the next real datapoint is 3 March, when the capital allocation review is due and the 2027 margin story gets its first hard look.